Bain Capital Life Sciences Investors, LLC Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$954.8B
Holdings
15
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (15 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 7,281,307 | $305.8B | 32.03% | |
| 2 | ARQTARCUTIS BIOTHERAPEUTICS, INC. | 3,979,292 | $120.3B | 12.60% | |
| 3 | —DICERNA PHARMACEUTICALS INC | 4,080,237 | $103.6B | 10.85% | |
| 4 | DVAXDYNAVAX TECHNOLOGIES CORP. | 10,895,773 | $96.6B | 10.12% | |
| 5 | —MERSANA THERAPEUTICS, INC. | 3,445,667 | $80.6B | 8.44% | |
| 6 | REPLREPLIMUNE GROUP INC | 2,162,598 | $53.7B | 5.63% | |
| 7 | —CONSTELLATION PHARMACEUTICALS INC. | 1,400,000 | $42.1B | 4.41% | |
| 8 | AGLEUSDAEGLEA BIOTHERAPEUTICS, INC. | 2,700,000 | $25.0B | 2.62% | |
| 9 | —APTINYX INC | 5,558,425 | $23.2B | 2.43% | |
| 10 | YB4PSAVARA INC | 5,128,593 | $23.0B | 2.41% | |
| 11 | SG7SAGE THERAPEUTICS, INC. | 499,100 | $20.8B | 2.17% | |
| 12 | CRNXCRINETICS PHARMACEUTICALS, INC. | 1,071,428 | $18.8B | 1.97% | |
| 13 | ASNSUSDX4 PHARMACEUTICALS INC | 1,648,485 | $15.4B | 1.61% | |
| 14 | —MARINUS PHARMACEUTICALS INC | 5,724,235 | $14.5B | 1.52% | |
| 15 | SLDBSOLID BIOSCIENCES INC | 3,871,164 | $11.3B | 1.19% |